Cutaneous Manifestations in Renal Transplant Recipients of Santiago, Chile

Simple item page
dc.contributor.authorSandoval, M.
dc.contributor.authorOrtiz, M.
dc.contributor.authorDiaz, C.
dc.contributor.authorMajerson, D.
dc.contributor.authorMolgo, M.
dc.date.accessioned2024-01-10T12:38:13Z
dc.date.available2024-01-10T12:38:13Z
dc.date.issued2009
dc.description.abstractIntroduction. Renal transplant recipients have a heightened risk of developing various cutaneous manifestations, such as skin infections, skin cancer, and secondary effects of immunosuppressive drugs. These manifestations differ depending on the evaluated population. The objective of this study was to describe the prevalence of cutaneous manifestations among renal transplant recipients in Chile between 1979 and 2008.
dc.description.abstractMethods. Patients were recruited and then evaluated using a standardized questionnaire. Dermatologic physical examination was performed in every patient describing skin lesions, immunosuppressive drug effects, and malignant diseases. All suspicious lesions were biopsied for analysis. Every patient was queried for the development of skin cancer after his or her transplantation.
dc.description.abstractResults. A total of 91 patients were enrolled; ages 10-67 years. Sixty percent of the patients presented with an infection at the initial evaluation. The most common infection was onychomycosis (58%) and verruca vulgaris (25%). In this study 58% of patients developed cutaneous side effects of immunosuppressive drugs. Among the evaluated patients, 16% showed premalignant or malignant manifestations on physical examination. The most frequent manifestations were actinic keratosis (17%), basal cell carcinoma (1%), and squamous cell carcinoma (1%). On a retrospective analysis, 12% of patients developed skin cancer after transplantation, 66% squamous cell carcinoma and 34% basal cell carcinoma, with a ratio of 1.9 to 1.
dc.description.abstractDiscussion. Cutaneous manifestations in renal transplant recipients are generally secondary to immunosuppression. These patients show a greater risk of having human papilloma virus (HPV) infections and nonmelanoma skin cancer. Periodic dermatologic evaluation of these patients should be performed to detect early lesions and modify risk factors.
dc.fechaingreso.objetodigital11-04-2024
dc.format.extent3 páginas
dc.fuente.origenWOS
dc.identifier.doi10.1016/j.transproceed.2009.05.041
dc.identifier.eissn1873-2623
dc.identifier.issn0041-1345
dc.identifier.pubmedidMEDLINE:19917380
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2009.05.041
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/77007
dc.identifier.wosidWOS:000272123900042
dc.information.autorucMedicina;Molgo M;S/I;100088
dc.issue.numero9
dc.language.isoen
dc.nota.accesoContenido parcial
dc.pagina.final3754
dc.pagina.inicio3752
dc.publisherELSEVIER SCIENCE INC
dc.revistaTRANSPLANTATION PROCEEDINGS
dc.rightsacceso restringido
dc.subjectSKIN-CANCER
dc.subjectPOPULATION
dc.subjectRISK
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleCutaneous Manifestations in Renal Transplant Recipients of Santiago, Chile
dc.typeartículo
dc.volumen41
sipa.codpersvinculados100088
sipa.indexWOS
sipa.indexScopus
sipa.trazabilidadCarga SIPA;09-01-2024
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
2024-04-11. Cutaneous Manifestations in Renal Transplant Recipients of Santiago, Chile.pdf
Size:
3.14 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas